Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer | Zendy

Aikou Okamoto | Zendy; Eiji Kondo | Zendy; Toshiaki Nakamura | Zendy; Satoshi Yanagida | Zendy; Junzo Hamanishi | Zendy; Kenichi Harano | Zendy; Kosei Hasegawa | Zendy; Takeshi Hirasawa | Zendy; Kensuke Hori | Zendy; Shinichi Komiyama | Zendy; Motoki Matsuura | Zendy; Hidekatsu Nakai | Zendy; Hiroko Nakamura | Zendy; Jun Sakata | Zendy; Tsutomu Tabata | Zendy; Kazuhiro Takehara | Zendy; Munetaka Takekuma | Zendy; Yoshihito Yokoyama | Zendy; Yoichi Kase | Zendy; Shuuji Sumino | Zendy; Junpei Soeda | Zendy; Ajit Suri | Zendy; Daisuke Aoki | Zendy; Toru Sugiyama | Zendy

Open Access

Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer

Author(s) -

Aikou Okamoto,

Eiji Kondo,

Toshiaki Nakamura,

Satoshi Yanagida,

Junzo Hamanishi,

Kenichi Harano,

Kosei Hasegawa,

Takeshi Hirasawa,

Kensuke Hori,

Shinichi Komiyama,

Motoki Matsuura,

Hidekatsu Nakai,

Hiroko Nakamura,

Jun Sakata,

Tsutomu Tabata,

Kazuhiro Takehara,

Munetaka Takekuma,

Yoshihito Yokoyama,

Yoichi Kase,

Shuuji Sumino,

Junpei Soeda,

Ajit Suri,

Daisuke Aoki,

Toru Sugiyama

Publication year - 2020

Publication title -

journal of gynecologic oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.358

H-Index - 37

eISSN - 2005-0399

pISSN - 2005-0380

DOI - 10.3802/jgo.2021.32.e16

Subject(s) - medicine , homologous recombination , ovarian cancer , homologous chromosome , oncology , cancer research , cancer , genetics , gene , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research